Reviewing Inogen (INGN) and Its Peers

Inogen (NASDAQ:INGN) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its competitors? We will compare Inogen to related businesses based on the strength of its valuation, earnings, dividends, profitability, institutional ownership, analyst recommendations and risk.

Volatility and Risk

Inogen has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, Inogen’s competitors have a beta of 2.57, indicating that their average share price is 157% more volatile than the S&P 500.

Institutional and Insider Ownership

89.9% of Inogen shares are held by institutional investors. Comparatively, 40.5% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 2.5% of Inogen shares are held by company insiders. Comparatively, 14.9% of shares of all “Healthcare Equipment & Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Inogen and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Inogen	-10.46%	-19.29%	-12.02%
Inogen Competitors	-304.20%	-315.07%	-22.11%

Analyst Recommendations

This is a summary of current ratings and target prices for Inogen and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inogen	1	0	0	1	2.50
Inogen Competitors	4291	10579	18364	831	2.46

As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 20.83%. Given Inogen’s competitors higher probable upside, analysts plainly believe Inogen has less favorable growth aspects than its competitors.

Earnings & Valuation

This table compares Inogen and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Inogen	$348.67 million	-$22.75 million	-4.34
Inogen Competitors	$1.90 billion	$135.83 million	5.88

Inogen’s competitors have higher revenue and earnings than Inogen. Inogen is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Inogen competitors beat Inogen on 7 of the 13 factors compared.

About Inogen

Inogen, Inc. is a medical technology company that develops, manufactures and markets portable oxygen concentrators for people who require long-term supplemental oxygen therapy. Its devices separate oxygen from ambient air and deliver concentrated oxygen without the need for traditional compressed-gas or liquid-oxygen tanks. The company’s product portfolio has included the Inogen One portable oxygen concentrator line, as well as stationary and related oxygen therapy products. These systems are designed to support mobility and independence for patients with chronic respiratory conditions while offering features such as rechargeable batteries, portability and various oxygen-delivery settings.